Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV

Mateo, R; Xu, SM; Shornikov, A; Yazdi, T; Liu, Y; May, L; Han, B; Han, D; Martin, R; Manhas, S; Richards, C; Marceau, C; Aeschbacher, T; Chang, SL; Manuilov, D; Hollnberger, J; Urban, S; Asselah, T; Abdurakhmanov, D; Lampertico, P; Maiorova, E; Mo, HM

Mateo, R (通讯作者),Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.

JHEP REPORTS, 2023; 5 (11):

Abstract

Background & Aims: Bulevirtide (BLV) is a small lipopeptide agent that specifically binds to the sodium taurocholate cotransporting polypeptide (N......

Full Text Link